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Aim: The aim of the present study was to ﬁnd out the impact of fat mass and
obesity-associated (FTO) gene on risk of pulmonary tuberculosis (PTB) in a sample of
Iranian population.Methods: This case-control study was carried out on a total of 354
subjects including 185 PTB patients and 169 healthy subjects. Genotyping of FTO
rs9939609 and rs8050136 variants was done using polymerase chain reaction-
restriction fragment length polymorphism method. Results: FTO rs9939609 variant
showed no statistically signiﬁcant difference in allele and genotype frequencies
between PTB patients and controls. The rs8050136 polymorphism marginally
increased the risk of PTB in dominant (OR= 1.53, 95% CI= 1.00–2.33,
p= 0.055, CA+AA vs. CC) inheritance model tested, where rs8050136 A allele
signiﬁcantly increased the risk of PTB (OR= 1.42, 95% CI= 1.02–1.97,
p= 0.045) compared with C allele. Conclusion: The ﬁnding of the present study
showed an association between FTO rs9939609 variant and risk of PTB. Further
studies with larger sample sizes and different ethnicities are necessary to conﬁrm the
ﬁndings.
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Introduction
Tuberculosis (TB) is a main health concern, affecting nearly one-third of the
world’s population [1, 2]. According to WHO report on global TB control,
approximately 8.6 million new cases occurred in 2012 [3]. It has been proposed
that 5%–10% of infected cases go on to develop active TB [3], which implies that
host genetics may inﬂuence the risk of the disease. Multiple lines of evidence
support a role for genetics in the development of pulmonary tuberculosis (PTB)
[4–9] in a sample of Iranian population.
The FTO gene is located on chromosome 16 (16q12.2). This gene encodes
a protein that plays a role in regulation of food intake [10]. Obesity inﬂuence
patterns of oxidative stress and altered circulating levels of inﬂammatory
cytokines, which impair immune function, modify leukocyte counts, and affect
cell-mediated immune responses [11–13]. There is growing evidence showing
that the impairment of the immune function leads to an increased susceptibility
of the host to a number of various pathogens, such as Mycobacterium tubercu-
losis, inﬂuenza, coxsackievirus, Helicobacter pylori, and encephalomyocarditis
virus [14–16].
FTO is the strongest known genetic susceptibility locus for obesity. The
genetic variants of FTO gene were found to be signiﬁcantly associated with
obesity in diverse populations [17–21].
To the best of our knowledge, there is only one report regarding the impact
of FTO gene polymorphisms on tuberculosis risk [22]. Thus, the present study
aimed to examine the possible associations between polymorphisms of FTO
rs9939609 and rs8050136 variants and susceptibility to PTB in a sample of Iranian
population.
Materials and Methods
Patients
This case-control study included 185 conﬁrmed PTB patients and 169
unrelated population-based healthy subjects. The cases were selected from PTB
patients admitted to a university-afﬁliated hospital (Bou-Ali Hospital, Zahedan,
referral center for TB). The enrolment procedures have been described previously
[23]. Brieﬂy, PTB diagnosis was done using clinical symptoms, chest radiogra-
phy, presence of acid-fast bacilli on a sputum smear, culturing M. tuberculosis
organisms, and response to antituberculosis chemotherapy. The project was
approved by the local ethics committee of the Zahedan University of Medical
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Sciences, and informed consent was taken from all subjects participated in
the study. Blood samples were collected in ethylenediaminetetraacetic acid-
containing tubes from patients and healthy controls, and genomic DNA was
extracted using salting out method as described previously [24].
Genotyping
Genotyping of FTO rs9939609 and rs8050136 polymorphisms was per-
formed using polymerase chain reaction-restriction fragment length polymor-
phism (PCR-RFLP) method. The set of primer sequences used in this method are
shown in Table I. In each 0.2-mL PCR reaction tube, 1 μL of genomic DNA
(~100 ng/mL), 1 μL of each primer (10 μM), 10 μL of 2× Prime Taq Premix
(GeNet Bio, Korea), and 7 μL of ddH2O were added.
Ampliﬁcation was done with an initial denaturation step at 95 °C for 5min,
followed by 30 cycles of 30 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C with a ﬁnal
step at 72 °C for 10 min. For rs9939609 and rs8050136 genotyping, 10 μL of PCR
products were digested withDdeI andMseI restriction enzymes (Fermentas, Vilnius,
Lithuania), respectively. Then, the fragments were separated by electrophoresis in
2% agarose gels. For rs9939609 variant, the A allele was digested into 173- and
27-bp fragments, whereas the T allele was undigested (200-bp fragment) (Figure 1).
Regarding rs8050136 variant, the A allele was digested into 182- and 24-bp
fragments, whereas the C allele was undigested (206-bp fragment) (Figure 2).
Statistical analysis
Statistical analysis was performed using the SPSS 20.0 package software.
The differences between the variables were evaluated by χ2-test or independent
sample t-test according to the data. The associations between genotypes and PTB
were estimated by computing the odds ratio (OR) and 95% conﬁdence intervals
(95% CI) from logistic regression analyses. A p-value of <0.05 was considered to
be statistically signiﬁcant.
Table I. The primers used for the detection of FTO gene polymorphisms using PCR-RFLP method
Polymorphisms Sequence (5′->3′)
Restriction
enzyme Product size (bp)
rs9939609 T>A F: TAGGTTCCTTGCGACTGCTGTGAACTT DdeI A allele: 173, 27
R: AGCCTCTCTACCATCTTATGTCCAAACA T allele: 200
rs8050136 C>A F: ATGCCAGTTGCCCACTGTGGCATT MseI A allele: 182, 24
R: GCAAAATTTCACACACCAAGATGGTCATG C allele: 206
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Results
A total of 354 subjects including 185 PTB patients (72 males, 113 females,
mean age: 50.0± 19.6 years) and 169 unrelated healthy subjects (75 males, 94
females, mean age: 47.9± 15.0 years) were evaluated. There was no statistically
signiﬁcant difference found between cases and controls regarding sex and age
(p> 0.05). Genotypes and allele frequencies of FTO gene polymorphisms are
shown in Table II. Allelic (A vs. T) and genotypic comparisons of codominant
Figure 2. Electrophoresis pattern of PCR-RFLP for the detection of FTO rs8050136 polymorphism.
The A allele was digested by MseI restriction enzyme into 182- and 24-bp fragments, whereas the
C allele was undigested (206-bp fragment). M: DNA marker; lanes 1, 4, and 7: CC; lanes 2, 5, and
8: CA; lanes 3 and 6: AA
Figure 1. Electrophoresis pattern of PCR-RFLP for the detection of FTO rs9939609 polymorphism.
The A allele was digested by DdeI restriction enzyme into 173- and 27-bp fragments, whereas the
T allele was undigested (200-bp fragment). M: DNA marker; lanes 1, 4, and 6: TA; lanes 2, 5, and
8: TT; lanes 3 and 7: AA
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(TA vs. TT and AA vs. TT), dominant (TA+AA vs. TT), and recessive (AA vs.
TA+TT) genetic inheritance models showed no signiﬁcant association between
rs9939609 T>A polymorphism and risk of PTB. Regarding rs8050136 C>A
polymorphism, this variant marginally increased the risk of PTB in dominant
(OR= 1.53, 95% CI= 1.00–2.33, p= 0.055, CA+AA vs. CC) inheritance
model tested, where rs8050136 A allele signiﬁcantly increased the risk of PTB
(OR= 1.42, 95% CI= 1.02–1.97, p= 0.045) compared with C allele.
The interaction of two polymorphisms on risk of PTB is shown in Table III.
The results revealed that AA/AA genotype marginally increased the risk of PTB
compared with rs9939609 TT/rs8050136 CC genotype.
Haplotype frequencies of FTO gene polymorphisms in PTB patients and
controls are shown in Table IV. The results revealed that AA haplotype marginally
associated with risk of PTB compared with rs9939609T/rs8050136C.
Table II. Genotype and allelic frequencies of FTO rs9939609 T>A and rs8050136 C>A variant in PTB
patients and control subjects
FTO polymorphism Case n (%) Control n (%) OR (95% CI) p
rs9939609 T>A
Codominant
TT 74 (40.0) 74 (43.8) 1.00 –
TA 95 (51.4) 86 (50.9) 1.11 (0.72–1.71) 0.659
AA 16 (8.6) 9 (5.3) 1.78 (0.74–4.28) 0.279
Dominant
TT 74 (40.0) 74 (43.8) 1.00 –
TA+AA 111 (60.0) 95 (56.2) 1.17 (0.76–1.78) 0.518
Recessive
TT+TA 169 (91.4) 160 (94.7) 1.00
AA 16 (8.6) 9 (5.3) 1.68 (0.72–3.92) 0.299
Allele
T 243 (65.7) 234 (69.2) 1.00 –
A 127 (34.3) 104 (30.8) 1.18 (0.86–1.61) 0.354
rs8050136 C>A
Codominant
CC 81 (43.8) 92 (54.5) 1.00 –
CA 90 (48.6) 70 (41.4) 1.46 (0.95–2.25) 0.100
AA 14 (7.6) 7 (4.1) 2.27 (0.87–5.90) 0.107
Dominant
CC 81 (43.8) 92 (54.5) 1.00 –
CA+AA 104 (56.2) 77 (45.5) 1.53 (1.00–2.33) 0.055
Recessive
CC+CA 171 (92.4) 162 (95.9) 1.00 –
AA 14 (7.6) 7 (4.1) 1.89 (0.74–4.81) 0.186
Allele
C 252 (68.1) 254 (75.1) 1.00 –
A 118 (31.9) 84 (24.9) 1.42 (1.02–1.97) 0.045
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Discussion
Obesity is identiﬁed to affect cell-mediated immune responses. Recent studies
have shown that genetic polymorphisms in the FTO gene are associated with human
obesity. In the present study, we examined the possible association between FTO
gene polymorphisms and the risk of PTB in a sample of Iranian population. Our
ﬁndings revealed that rs9939609 variant was not associated with the risk of PTB,
whereas the rs8050136 C>A variant marginally increased the risk of PTB in
dominant inheritance model. The rs8050136 A allele signiﬁcantly increased the risk
of PTB compared with C allele. In contrast to our ﬁndings, Feng et al. [22] have
found a signiﬁcant association between FTO rs9939609 polymorphism and risk of
TB. The AA genotype signiﬁcantly increased the risk of TB compared with TT
genotype (OR= 3.77, 95% CI= 2.26–6.28, p< 0.001). Furthermore, the A allele
increased the risk of TB (OR= 1.26, 95% CI= 1.08–1.48, p= 0.004). But, they did
not ﬁnd an association between rs8050136 variant and risk of TB.
It has been proposed that obesity is a risk factor for cancer. Several studies
have shown that FTO gene polymorphisms may be signiﬁcantly associated with
risk of various cancers [25, 26].
The effect of FTO gene variant on the risk of PTB may not merely be
attributed to its role in the risk of obesity. The alteration of human immune
response related to this genetic variant may play a role.
Table III. Interaction of FTO rs9939609 T>A and rs8050136 C>A polymorphisms with PTB risk
rs9939609 T>A rs8050136 C>A PTB n (%) Controls n (%) OR (95% CI) p
TT CC 68 (36.8) 72 (42.6) 1.00 –
TA CA 83 (44.9) 64 (37.9) 1.42 (0.89–2.26) 0.158
TA CC 12 (6.5) 20 (11.8) 0.64 (2.89–1.40) 0.326
AA AA 14 (7.6) 5 (3.0) 2.96 (1.01–8.68) 0.051
TT CA 6 (3.2) 2 (1.2) 3.18 (0.62–16.29) 0.275
AA CA 2 (1.1) 4 (2.4) 0.52 (0.09–2.99) 0.683
TA AA 0 (0.0) 2 (1.2) – –
Table IV. Haplotype association of FTO rs9939609 T>A and rs8050136 C>A variants with PTB risk
rs9939609
T>A
rs8050136
C>A
PTB
(Frequency)
Control
(Frequency) OR (95% CI) p
T C 0.6397 0.6794 1.00 –
A A 0.3019 0.2356 1.39 (0.96–2.02) 0.078
A C 0.0414 0.0721 0.64 (0.32–1.28) 0.210
T A 0.0170 0.0129 1.48 (0.40–5.41) 0.560
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The present study has several limitations. First, we have no data regarding
body mass index prior to the diagnosis of tuberculosis, and we could not
determine the effect of FTO variants on obesity. Second, we only selected two
variants in the FTO gene. Third, we did not determine the gene environmental
interactions. Finally, we had no data regarding BCG vaccination of cases and
controls.
In summary, our ﬁndings revealed an association between rs8050136
variant of FTO gene and risk of PTB in a sample of Iranian population. The
possible mechanisms that could explain this association remains to be clear.
Further studies with larger sample sizes and different ethnicities are necessary to
conﬁrm these ﬁndings.
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